News

home News

[220722 Àú³Î¹ßÇ¥] Alzheimer¡¯s disease: Ablating single master site abolishes tau hyperphosphorylation

À̵¿ÁØ ¦¢ 2022-07-22

HIT

46421

2022 Jul 8;8(27):eabl8809.
 doi: 10.1126/sciadv.abl8809. Epub 2022 Jul 6.

Alzheimer's disease: Ablating single master site abolishes tau hyperphosphorylation

Affiliations 

Abstract

Hyperphosphorylation of the neuronal tau protein is a hallmark of neurodegenerative tauopathies such as Alzheimer's disease. A central unanswered question is why tau becomes progressively hyperphosphorylated. Here, we show that tau phosphorylation is governed by interdependence- a mechanistic link between initial site-specific and subsequent multi-site phosphorylation. Systematic assessment of site interdependence identified distinct residues (threonine-50, threonine-69, and threonine-181) as master sites that determine propagation of phosphorylation at multiple epitopes. CRISPR point mutation and expression of human tau in Alzheimer's mice showed that site interdependence governs physiologic and amyloid-associated multi-site phosphorylation and cognitive deficits, respectively. Combined targeting of master sites and p38¥á, the most central tau kinase linked to interdependence, synergistically ablated hyperphosphorylation. In summary, our work delineates how complex tau phosphorylation arises to inform therapeutic and biomarker design for tauopathies.




Prev [220722 Àú³Î¹ßÇ¥] Absence of microglia promotes diverse pathologies and early le...
Next [220819 Àú³Î¹ßÇ¥] An IL1RL1 genetic variant lowers soluble ST2 levels and the ri...